Susan E Quaggin, MD
Disclosures: Consulting Fee-Current-AstraZeneca|Ownership Interest-current-Mannin Research|Consulting Fee-Current-Janssen|Chief Scientific Officer-Current-Mannin|Consulting Fee-Current-Roche
No Bio Available.